Interleukin-2 in outpatients with renal cell carcinoma: SCAPP1 trial.
Tourani
J M
JM
Oncology Unit, Laennec Hospital, Paris, France.
Grise
P
P
Lucas
V
V
Mayeur
D
D
Dufour
B
B
Di Palma
M
M
Boaziz
C
C
Pavlovitch
J M
JM
Pujade-Lauraine
E
E
Larregain
D
D
Untereiner
M
M
D000328:Adult; D000368:Aged; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010045:Outpatients; D011994:Recombinant Proteins / Q000627:therapeutic use
D007376:Interleukin-2; D011994:Recombinant Proteins